Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation

British Journal of Surgery

Volumn 99, Issue 7, 2012, Pages 897-909

  Glynne Jones, R ^a   Hughes, R ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862771914     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8732     Document Type: Review

References (85)

1. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H,Wiggers T et al.; Dutch Colorectal Cancer Group. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246: 693-701. (Pubitemid 350035641)
2. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373: 811-820.
3. van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H,Wiggers T et al.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011; 12: 575-582.
4. Sauer R, Becker H, HohenbergerW, Rodel C,Wittekind C, Fietkau R et al.; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
5. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L et al.; EORTC Radiotherapy Group Trial 22921. Chemoradiotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123. (Pubitemid 44394918)
6. Gérard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-T4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006; 24: 4620-4625. (Pubitemid 46630960)
7. Roh MS, Colangelo LH, O'Connell MJ, Yothers G, Deutsch M, Alegra CJ et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R03. J Clin Oncol 2009; 27: 5124-5130.
8. Paun BC, Cassie S, MacLean AR, Dixon E, BuieWD. Postoperative complications following surgery for rectal cancer. Ann Surg 2010; 251: 807-818.
9. Borowski DW, Bradburn DM, Mills SJ, Bharathan B, Wilson RG, Ratcliffe AA et al.; Northern Region Colorectal Cancer Audit Group (NORCCAG). Volume-outcome analysis of colorectal cancer-related outcomes. Br J Surg 2010; 97: 1416-1430.
10. Rutten HJ, den Dulk M, Lemmens VE, van de Velde CJ, Marijnen CA. Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 2008; 9: 494-501. (Pubitemid 351626863)
11. Gervaz PA,Wexner SD, Pemberton JH. Pelvic radiation and anorectal function: introducing the concept of sphincter-preserving radiation therapy. J Am Coll Surg 2002; 195: 387-394. (Pubitemid 35006295)
12. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, MichalskiW, Bebenek M, Kryj M. Long-Term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-1223. (Pubitemid 44547018)
13. Braendengen M, Tveit KM, Berglund A, Birkmeyer E, Frykholm G, Påhlman L et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008; 26: 3687-3694.
14. Hartley A, Ho K, McConkey C, Geh JI. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol 2005; 78: 934-938. (Pubitemid 41582245)
15. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ et al. Long-Term outcome in patients with a pathological complete response after chemoradiation for rectal cancer. Lancet Oncol 2010; 11: 835-844.
16. Papillon J. Rectal and Anal Cancers: Conservative Treatment by Radiation. An Alternative to Surgery. Springer: New York 1982.
17. Gerard JP, Chapet O, Ramailoli A, Romestaing P. Long term control of T2-T3 rectal adenocarcinoma with radiotherapy alone. Int J Radiat Oncol Phys 2002; 54: 142-149.
18. Habr-Gama A, de Souza PM, Ribeiro U, Nadalin W, Gansl R, Sousa AH Jr. et al. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 1998; 41: 1087-1096. (Pubitemid 28432448)
19. Habr-Gama A, de Souza PM, Ribeiro U. Multimodality therapy in low rectal cancer: long-Term outcome of complete responders. Dis Colon Rectum 2001; 44: A18.
20. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr., Silva e Sousa AH Jr. et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long term results. Ann Surg 2004; 240: 711-717.
21. Habr-Gama A, Perez RO, Nadalin W, Nahas SC, Ribeiro U Jr., Silva E Sousa AH Jr. et al. Long term results of preoperative chemoradiation for distal rectal cancer: correlation between final stage and survival. J Gastrointest Surg 2005; 9: 90-109.
22. Habr-Gama A, Perez RO, Proscurshim I, Campos FG, Nadalin W, Kiss D et al. Patterns of failure and survival for non-operative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006; 10: 1319-1328.
23. Habr-Gama A. Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy. Colorectal Dis 2006; 8(Suppl 3): 21-24.
24. Habr-Gama A, Perez RO, São Julião GP, Proscurshim I, Nahas SC, Gama-Rodrigues J. Factors affecting management decisions in rectal cancer in clinical practice: results from a national survey. Tech Coloproctol 2011; 15: 45-51.
25. Habr-Gama A, Perez RO, São Julião GP, Proscurshim I, Gama-Rodrigues J. Nonoperative approaches to rectal cancer: a critical evaluation. Semin Radiat Oncol 2011; 21: 234-249.
26. Dalton R, Velineni R, Osborne M, Thomas R, Harries S, Gee A et al. A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? Colorectal Dis 2012; 14: 567-571.
27. Maas M, Beets-Tan RG, Lambregts DM, Lammering G, Nelemans PJ, Engelen SM et al.Wait-And-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol 2011; 29: 4633-4640.
28. Habr-Gama A, Perez R, Proscurshim I, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer. Surg Oncol Clin N Am 2010; 19: 829-845.
29. Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J. Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 2010; 53: 1692-1698.
30. Habr-Gama A, Perez RO, Sabbaga J, Nadalin W, São Julião GP, Gama-Rodrigues J. Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period. Dis Colon Rectum 2009; 52: 1927-1934.
31. Habr-Gama A, Perez RO, Proscurshim I, Nunes Dos Santos RM, Kiss D, Gama-Rodrigues J et al. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome? Int J Radiat Oncol Biol Phys 2008; 71: 1181-1188.
32. Habr-Gama A, Perez RO. Non-operative management of rectal cancer after neoadjuvant chemoradiation. Br J Surg 2009; 96: 125-127.
33. Habr-Gama A, Gama-Rodrigues J, Perez RO, Proscurshim I, São Julião GP, Kruglensky D et al. Late assessment of local control by PET in patients with distal rectal cancer managed non-operatively after complete tumor regression following neoadjuvant chemoradiation. Tech Coloproctol 2008; 12: 74-76. (Pubitemid 351782237)
34. Perez RO, São Julião GP, Habr-Gama A, Kiss D, Proscurshim I, Campos FG et al. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemotherapy for distal rectal cancer. Dis Colon Rectum 2009; 52: 1137-1143.
35. Perez RO, Habr-Gama A, Gama-Rodrigues J, Proscurshim I, Julião GP, Lynn P et al. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-Term results of a prospective trial (National Clinical Trial 00254683). Cancer 2011 [Epub ahead of print 15 November 2011].
36. Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Scanavini Neto A, Gama-Rodrigues J. Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates. Dis Colon Rectum 2011; 54: 545-551.
37. Perez RO, Pereira DD, Proscurshim I, Gama-Rodrigues J, Rawet V, São Julião GP et al. Lymph node size in rectal cancer following neoadjuvant chemoradiation -can we rely on radiologic nodal staging after chemoradiation? Dis Colon Rectum 2009; 52: 1278-1284.
38. Gerard JP, Ayzac L, Coquard R, Romestaing P, Ardiet JM, Rocher FP et al. Endocaviatry irradiation for early rectal carcinomas T1 (T2). A series of 101 patients treated with the Papillon's technique. Int J Radiat Biol Phys 1996; 34: 775-783. (Pubitemid 26089214)
39. Rossi B, Nakagawa W, Novaes P, FilhoWD, Lopes A. Radiation and chemotherapy instead of surgery for low infiltrative rectal adenocarcinoma: a prospective trial. Ann Surg Oncol 1998; 5: 113-118. (Pubitemid 29071279)
40. Birnbaum EH, Ogunbiyi OA, Gagliardi G, Fry RD, Myerson RJ, Kodner IJ et al. Selection criteria for treatment of rectal cancer with combined external beam and endocavitary radiation. Dis Colon Rectum 1999; 42: 727-733.
41. Nakagawa W, Rossi B, de O Ferreira F, Ferrigno R, Filho P, Nishimoto I et al. Chemoradiation instead of surgery to treat mid and low rectal tumors: is it safe? Ann Surg Oncol 2002; 9: 568-573. (Pubitemid 34774418)
42. Wang Y, Cummings B, Catton P, Dawson L, Kim J, Ringash J et al. Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients. Radiother Oncol 2005; 77: 126-132. (Pubitemid 41682376)
43. Lim L, Chao M, Shapiro J, Millar JL, Kipp D, Rezo A et al. Long term outcomes of patients with localized rectal cancer treated with chemoradiation or radiotherapy alone because of medical inoperability or patient refusal. Dis Colon Rectum 2007; 50: 2032-2039. (Pubitemid 350275863)
44. Hughes R, Harrison M, Glynne-Jones R. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy? Acta Oncol 2010; 49: 378-381.
45. Seshadri R. Clinical complete response following neoadjuvant chemoradiation for rectal cancers: can surgery be avoided?. Ann Oncol 2011; 22(Suppl 5): v133 (abstract P-0410).
46. Yu SK, Brown G, Heald RJ. Deferral of rectal surgery following a continued response to preoperative chemoradiotherapy (Watch and Wait) study: a phase II multicenter study in the United Kingdom. J Clin Oncol 2011; 29(Suppl 4): abstract 489.
47. O'Neill B, Brown G, Heald R, Cunningham D, Tait DM. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 2007; 8: 625-633. (Pubitemid 47008889)
48. Caricato M, Ausania F, Coppola R. Surgical treatment of rectal cancer after neoadjuvant chemoradiation. Where are we going? Surg Oncol 2007; 16(Suppl 1): S91-S92.
49. Glynne-Jones R, Wallace M, Livingstone JI, Meyrick-Thomas J. Complete clinical response after preoperative chemoradiation in rectal cancer: is a 'wait and see' policy justified? Dis Colon Rectum 2008; 51: 10-19.
50. Higgins KA,Willett CG, Czito BG. Nonoperative management of rectal cancer: current perspectives. Clin Colorectal Cancer 2010; 9: 83-88.
51. Singh-Ranger G, Kumar D. Current concepts in the non-operative management of rectal cancer after neoadjuvant chemoradiation. Anticancer Res 2011; 31: 1795-1800.
52. Smith FM, Waldron D,Winter DC. Rectum-conserving surgery in the era of chemoradiotherapy. Br J Surg 2010; 97: 1752-1764.
53. Mulsow J, Winter DC. Sphincter preservation for distal rectal cancer -A goal worth achieving at all costs? World J Gastroenterol 2011; 17: 855-861.
54. Rouanet P. [Complete response for rectal carcinoma after neoadjuvant therapy: to operate or not to operate? Surgeon's view.] Bull Cancer 2011; 98: 25-29.
55. Wynn GR, Bhasin N, Macklin CP, George ML. Complete clinical response to neoadjuvant chemoradiotherapy in patients with rectal cancer: opinions of British and Irish specialists. Colorectal Dis 2010; 12: 327-333.
56. Benzoni E, Cerato F, Cojutti A, Milan E, Pontello D, Chiaulon G et al. The predictive value of clinical evaluation of response to neoadjuvant chemoradiation therapy for rectal cancer. Tumori 2005; 91: 401-405. (Pubitemid 41719694)
57. Zmora O, Dasilva GM, Gurland B, Pfeffer R, Koller M, Nogueras JJ et al. Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy? Dis Colon Rectum 2004; 47: 1607-1612. (Pubitemid 39331970)
58. Guillem J, Chessin D, Shia J, Moore HG, Mazumdar M, Bernard B et al. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J Clin Oncol 2005; 23: 3475-3479.
59. Lambregts DM, Maas M, Bakers FC, Cappendijk VC, Lammering G, Beets GL et al. Long-Term follow-up features on rectal MRI during a wait-And-see approach after a clinical complete response in patients with rectal cancer treated with chemoradiotherapy. Dis Colon Rectum 2011; 54: 1521-1528.
60. Borschitz T,Wachtlin D, Möhler M, Schmidberger H, Junginger T. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 2008; 15: 712-720.
61. Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S et al. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol 2010; 17: 441-447.
62. RiderWD. The 1975 Gordon Richards Memorial Lecture. Is the Miles operation really necessary for the treatment of rectal cancer? J Can Assoc Radiol 1975; 26: 167-175.
63. Rich TA. Infusional chemoradiation for operable rectal cancer: post-, pre-, or nonoperative management? Oncology (Williston Park) 1997; 11: 295-300, 305.
64. Rich TA, Gunderson LL. Radical nonoperative management of early rectal cancer. Int J Radiat Oncol Biol Phys 1995; 31: 677-678.
65. den Dulk M, van de Velde CJ. Considerations and restrictions for non-operative treatment of rectal cancer in selected patients. Lancet Oncol 2007; 8: 570-571.
66. Nyasavajjala SM, Shaw AG, Khan AQ, Brown SR, Lund JN. Neoadjuvant chemo-radiotherapy and rectal cancer: can the UK watch and wait with Brazil? Colorectal Dis 2010; 12: 33-36.
67. dos Santos LV, dos Anjos Jácome AA, Cárcano FM, da Silveira Nogueira Lima JP, Serrano SV.Watch and wait policy remains experimental for the management of rectal cancer. Colorectal Dis 2010; 12: 833.
68. Anwar S.Watch and wait policy remains experimental for the management of rectal cancer. Colorectal Dis 2010; 12: 1167-1168.
69. Kim CJ, Yeatman TJ, Coppula D, Trotti A, Williams B, Barthel JS et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 2001; 234: 352-358.
70. Mohiuddin M, Marks G, Bannon J. High-dose preoperative radiation and full thickness local excision: a new option for selective T3 distal rectal cancers. Int J Radiat Oncol Biol Phys 1994; 30: 845-849. (Pubitemid 24355935)
71. Onaitis MW, Noone RB, Fields R, Hurwitz H, Morse M, Jowell P et al. Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann Surg Oncol 2001; 8: 801-806. (Pubitemid 34003329)
72. Schell SR, Zlotecki RA, Mendenhall WM, Marsh RW, Vauthey JN, Copeland EM III. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg 2002; 194: 584-590.
73. Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M et al. Long-Term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys 2004; 60: 1098-1105. (Pubitemid 39440794)
74. Hughes R, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M et al. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int J Colorectal Dis 2006; 21: 11-17. (Pubitemid 41829760)
75. Patel UB, Taylor F, Blomqvist L, George C, Evans H, Tekkis P et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011; 29: 3753-3760.
76. van den Brink M, Stiggelbout A, van den Hout W, Kievit J, Klein Kranenbarg E, Marijnen CA et al. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol 2004; 22: 3958-3964. (Pubitemid 41079878)
77. Merkel S, Mansmann U, Hohenberger W, Hermanek P. Time to locoregional recurrence after curative resection of rectal carcinoma is prolonged after neoadjuvant treatment: a systematic review and meta-Analysis. Colorectal Dis 2011; 13: 123-131.
78. Leibold T, Shia J, Ruo L, Minsky BD, Akhurst T, Gollub MJ et al. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol 2008; 26: 2106-2111.
79. Moore HG, Gittleman AE, Minsky BD, Wong D, Patey PB, Weiser M et al. Rate of pathological complete response with increased interval between preoperative combined modality therapy in rectal cancer resection. Dis Col Rectum 2004; 47: 279-286. (Pubitemid 38280578)
80. Glehen O, Chapet O, Adham M, Nemoz JC, Gerard JP; Lyons Oncology Group. Long-Term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg 2003; 90: 996-998. (Pubitemid 37026330)
81. Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM; Timing of Rectal Cancer Response to Chemoradiation Consortium. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg 2011; 254: 97-102.
82. Harrison JD, Solomon MJ, Young JM, Meagher A, Butow P, Salkeld G et al. Patient and physician preferences for surgical and adjuvant treatment options for rectal cancer. Arch Surg 2008; 43: 389-394. (Pubitemid 351574858)
83. Zolciak A, Bujko K, Kepka L, Oledzki J, Rutkowski A, Nowacki MP. Abdominoperineal resection or anterior resection for rectal cancer: patient preferences before and after treatment. Colorectal Dis 2006; 8: 575-580. (Pubitemid 44210109)
84. Masya LM, Young JM, Solomon MJ, Harrison JD, Dennis RJ, Salkeld GP. Preferences for outcomes of treatment for rectal cancer: patient and clinician utilities and their application in an interactive computer-based decision aid. Dis Colon Rectum 2009; 52: 1994-2002.
85. Neuman HB, Elkin EB, Guillem JG, Paty PB, Weiser MR, Wong WD et al. Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysis. Dis Colon Rectum 2009; 52: 863-871.